Evidence map›Paper›PMID 32344426›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2020

Effects of muscarinic M

Pia Weikop, Kathrine L Jensen, Morgane Thomsen

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. MPharmacology research & perspectives · 2022
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Pia Weikop *Laboratory of Neuropsychiatry, Mental Health Services in the Capital Region of Denmark and University of Copenhagen, 2100, Copenhagen, Denmark.
Kathrine L Jensen *Molecular Neuropharmacology and Genetics Laboratory, Department of Neuroscience, Faculty of Health and Medical Sciences, The Panum Institute, University of Copenhagen, 2200, Copenhagen, Denmark.ORCID http://orcid.org/0000-0001-8985-9126
Morgane ThomsenLaboratory of Neuropsychiatry, Mental Health Services in the Capital Region of Denmark and University of Copenhagen, 2100, Copenhagen, Denmark. morgane.hermann.thomsen@regionh.dk.
University of Copenhagen · DK

Funding

Selective Muscarinic Receptor Ligands as Targets for Cocaine Addiction MedicationR00DA027825 · NIDA · MCLEAN HOSPITAL · PI THOMSEN, MORGANE HERMANN · 2012 to 2014
$710k
Selective Muscarinic Receptor Ligands as Targets for Cocaine Addiction MedicationK99DA027825 · NIDA · MCLEAN HOSPITAL · PI THOMSEN, MORGANE HERMANN · 2010 to 2011
$247k
NIDA NIH HHS K99 DA027825NIDA NIH HHS R00 DA027825
6 · The paper itself

Abstract

Cocaine addiction is a chronic illness characterized by maladaptive drug-induced neuroplastic changes that confer lasting vulnerability to relapse. Over several weeks we observed the effects of the M

Indexed as

CocaineCocaine-Related DisordersAnimalsCholinergic AgentsDopamine Uptake InhibitorsMaleMicrodialysisNucleus AccumbensRatsSelf AdministrationCholinergic AgentsCocaineDopamine Uptake Inhibitors

Identifiers

PMID32344426
PMCPMC7547714
OpenAlexW3017903966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.